This trial will recruit 210 Veterans meeting DSM-IV criteria for PTSD , with testing conducted at 0 and 3 months for PTSD symptoms , depression , mood disturbance , quality of life , behavioral factors , and physiological/biochemical and gene expression mechanisms using validated measures .